These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Attempt at sustained treatment with nitrogen mustards in mycosis fungoides in the pretumoral stage]. MICHEL PJ; MOREL R; MORETEAU JJ Bull Soc Fr Dermatol Syphiligr; 1952; 59(1):46-8. PubMed ID: 12978770 [No Abstract] [Full Text] [Related]
6. Focal contact sensitivity to nitrogen mustard in lesions of cutaneous T-cell lymphoma (mycosis fungoides). Shelley WB Acta Derm Venereol; 1981; 61(2):161-4. PubMed ID: 6165197 [TBL] [Abstract][Full Text] [Related]
7. Nitrogen mustards in the treatment of neoplastic disease. KARNOFSKY DA Adv Intern Med; 1950; 4():1-75. PubMed ID: 14770961 [No Abstract] [Full Text] [Related]
8. Second cutaneous malignancies in patients with mycosis fungoides treated with topical nitrogen mustard. Lee LA; Fritz KA; Golitz L; Fritz TJ; Weston WL J Am Acad Dermatol; 1982 Nov; 7(5):590-8. PubMed ID: 7142467 [TBL] [Abstract][Full Text] [Related]
9. Mycosis fungoides. Topical use of nitrogen mustard in recurrent cases. Arundell FD; Chan WH Calif Med; 1968 Dec; 109(6):458-61. PubMed ID: 5724878 [TBL] [Abstract][Full Text] [Related]
11. Management of Mycosis Fungoides with Topical Chlormethine/Mechlorethamine Gel: A Columbia University Cutaneous Lymphoma Center Experience. Garcia-Saleem TJ; Stonesifer CJ; Khaleel AE; Geskin LJ Acta Derm Venereol; 2021 Sep; 101(9):adv00544. PubMed ID: 34436621 [TBL] [Abstract][Full Text] [Related]
12. Mycosis fungoides plaque stage treated with topical nitrogen mustard with and without attempts at tolerance induction: report from the Scandinavian mycosis fungoides study group. Molin L; Thomsen K; Volden G Acta Derm Venereol; 1979; 59(1):64-8. PubMed ID: 84470 [TBL] [Abstract][Full Text] [Related]
13. Mechlorethamine gel for the topical treatment of stage IA and IB mycosis fungoides-type cutaneous T-cell lymphoma. Talpur R; Venkatarajan S; Duvic M Expert Rev Clin Pharmacol; 2014 Sep; 7(5):591-7. PubMed ID: 25068889 [TBL] [Abstract][Full Text] [Related]
15. Photochemotherapy and topical nitrogen mustard in the treatment of mycosis fungoides. du Vivier A; Vollum DI Br J Dermatol; 1980 Mar; 102(3):319-22. PubMed ID: 7370179 [TBL] [Abstract][Full Text] [Related]
16. Topical nitrogen mustard in mycosis fungoides. Zachariae H Int J Clin Pharmacol Res; 1985; 5(3):193-8. PubMed ID: 4018954 [TBL] [Abstract][Full Text] [Related]
17. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part II. Prognosis, management, and future directions. Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C J Am Acad Dermatol; 2014 Feb; 70(2):223.e1-17; quiz 240-2. PubMed ID: 24438970 [TBL] [Abstract][Full Text] [Related]
18. Topical nitrogen mustard in early mycosis fungoides. A 12-year experience. Zachariae H; Thestrup-Pedersen K; Søgaard H Acta Derm Venereol; 1985; 65(1):53-8. PubMed ID: 2578706 [TBL] [Abstract][Full Text] [Related]
19. Clinical potential of mechlorethamine gel for the topical treatment of mycosis fungoides-type cutaneous T-cell lymphoma: a review on current efficacy and safety data. Liner K; Brown C; McGirt LY Drug Des Devel Ther; 2018; 12():241-254. PubMed ID: 29440874 [TBL] [Abstract][Full Text] [Related]
20. Frequent low doses of intravenous mechlorethamine for late-stage mycosis fungoides lymphoma. Van Scott EJ; Grekin DA; Kalmanson JD; Vonderheid EC; Barry WE Cancer; 1975 Nov; 36(5):1613-8. PubMed ID: 1192353 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]